Hansted Edita, Andriuskeviciene Angele, Sakalauskas Raimundas, Kevalas Rimantas, Sitkauskiene Brigita
Department of Pediatric Diseases, Kaunas University of Medicine, Eiveniu 2, 50009 Kaunas, Lithuania.
BMC Pulm Med. 2009 Aug 18;9:41. doi: 10.1186/1471-2466-9-41.
Lithuania is a country with a high incidence of tuberculosis (TB), despite a high coverage with bacille Calmette-Guerin (BCG) vaccination. Until now the only method used to detect latent TB infection was the tuberculin skin test (TST). However, TST may have a cross reactivity to the BCG vaccine and to environmental mycobacteria. The aim of this study was to conduct assessments of the diagnostic accuracy of the T-cell based test (T SPOT TB) for TB in children who had previously been BCG vaccinated and compare these with the results of the TST.
Between January 2005 and February 2007, children with bacteriologically confirmed TB, children having contacts with a case of infectious pulmonary TB and children without any known risk for TB were tested with both the TST and T SPOT TB.
The TST and T SPOT TB tests were positive for all patients in the "culture-confirmed TB" group. Whereas, in the "high risk for TB" group, the TST was positive for 60%, but the T SPOT TB test, only for 17.8%. Meanwhile the results for the "low risk for TB" group were 65.4% and 9.6%, respectively. A correlation between the TST and T SPOT TB was obtained in the "culture-confirmed TB" group where the TST > or =15 mm (r = 0.35, p < 0.001).
The T-cell based method is more objective than the TST for identifying latent TB infection in children who had been previously BCG vaccinated. This method could be useful in countries like Lithuania where there is a high incidence of TB despite a high coverage with BCG vaccination. It may also help to avoid unnecessary chemoprophylaxis when TST reactions are false-positive.
立陶宛是一个结核病(TB)发病率较高的国家,尽管卡介苗(BCG)接种覆盖率很高。到目前为止,用于检测潜伏性结核感染的唯一方法是结核菌素皮肤试验(TST)。然而,TST可能与BCG疫苗和环境分枝杆菌存在交叉反应。本研究的目的是评估基于T细胞的检测方法(T SPOT TB)对既往接种过BCG疫苗的儿童结核病的诊断准确性,并将其与TST的结果进行比较。
2005年1月至2007年2月期间,对细菌学确诊的结核病患儿、接触过传染性肺结核病例的儿童以及无任何已知结核病风险的儿童进行了TST和T SPOT TB检测。
“培养确诊结核病”组的所有患者TST和T SPOT TB检测均为阳性。而在“结核病高风险”组中,TST阳性率为60%,但T SPOT TB检测仅为17.8%。同时,“结核病低风险”组的结果分别为65.4%和9.6%。在“培养确诊结核病”组中,当TST≥15 mm时,TST与T SPOT TB之间存在相关性(r = 0.35,p < 0.001)。
对于既往接种过BCG疫苗的儿童,基于T细胞的方法在识别潜伏性结核感染方面比TST更客观。这种方法在像立陶宛这样尽管BCG疫苗接种覆盖率很高但结核病发病率仍很高的国家可能有用。当TST反应为假阳性时,它也可能有助于避免不必要的化学预防。